Skip to main content
AI/ML Innovations Inc. logo

AI/ML Innovations Inc. — Investor Relations & Filings

Ticker · AIML ISIN · CA00143Y1034 LEI · 5493004TJHMBXORVTD12 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 532 across all filing types
Latest filing 2022-07-07 Regulatory Filings
Country CA Canada
Listing CSE AIML

About AI/ML Innovations Inc.

https://aiml-innovations.com/

AI/ML Innovations Inc. is a digital healthcare technology company specializing in the application of Artificial Intelligence (AI) and Machine Learning (ML) neural networks to revolutionize non-invasive medicine and biometric intelligence. The company develops proprietary platforms that leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights, supporting proactive and personalized care. Its flagship technology, MaxYield, is a cutting-edge Signal Processing Neural Network designed to extract high-fidelity signals from noisy recordings, initially focused on enhancing the clarity and accuracy of ECG data by delivering clean, "Neuralized" waveforms and precise PQRST data walls. Through its subsidiaries, the company provides AI-powered solutions like CardioYield™ for Holter analysis, aiming to integrate seamlessly with existing clinical and wellness workflows.

Recent filings

Filing Released Lang Actions
Form of proxy - English.pdf
Regulatory Filings Classification · 100% confidence The document is a certification letter by the CFO of RepliCel Life Sciences Inc. regarding the interim financial report and interim MD&A for the period ended March 31, 2022. It is titled 'Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate' and contains no actual financial data or substantive financial analysis, only attestations about the accuracy and fair presentation of the interim filings. The document is short (3011 characters) and primarily serves as an officer certification rather than the interim report itself. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR).
2022-07-07 English
Notice of meeting - English.pdf
AGM Information Classification · 95% confidence The document is a Notice of Annual Meeting of Shareholders for AI/ML Innovations Inc., detailing the date, location, and agenda items for the meeting, including election of directors, acceptance of audited financial statements, and appointment of auditors. It is a formal announcement inviting shareholders to attend and vote, not the actual meeting materials or results. The document length is short (2410 characters) and it serves as a notification rather than a report or detailed presentation. Therefore, it fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, or more precisely, the notice of the AGM itself. Given the content and purpose, AGM-R is the most appropriate classification with high confidence.
2022-07-07 English
Management information circular - English.pdf
Regulatory Filings
2022-07-07 English
Other.pdf
Regulatory Filings Classification · 95% confidence The document is a form for shareholders to request receiving Interim Financial Statements and/or Annual Financial Statements by mail or email. It does not contain any actual financial data or analysis, nor does it present the financial statements themselves. It is essentially a mailing request form related to financial reports, not the reports themselves. The document length is short (1444 characters), and it serves as a communication or request form rather than a report or announcement of results. Therefore, it fits best under Regulatory Filings (RNS) as a miscellaneous regulatory communication that does not fit other categories.
2022-07-07 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing that a subsidiary of AI/ML Innovations Inc. has started the ISO 13485 certification process for medical devices. It contains no financial statements, no detailed financial performance data, no regulatory filings, no voting results, no management or board changes, no earnings data, and no detailed investor presentation. It is a corporate announcement about a certification process and business update. The document length is 5487 characters, which is relatively short and consistent with a news release. There is no indication that this is a report or a filing of any kind, nor is it a proxy, dividend, or capital change announcement. The content fits best under a general regulatory announcement or corporate news release category. According to the classification rules, such announcements that do not fit other categories are best classified as Regulatory Filings (RNS).
2022-06-22 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2022-06-11 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.